← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2020Last known activity
Nov 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 7 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Recent trials (19)
- NCT07115056Lead sponsorPhase 4Nov 1, 2025
- NCT07115056Sponsor investigatorPhase 4Nov 1, 2025
- NCT07024654OfficialPhase 2Jun 30, 2025
- NCT07024654Sponsor investigatorPhase 2Jun 30, 2025
- NCT07024654Lead sponsorPhase 2Jun 30, 2025
- NCT06618820Lead sponsorPhase 3Sep 17, 2024
- NCT06618820Sponsor investigatorPhase 3Sep 17, 2024
- NCT06618820OfficialPhase 3Sep 17, 2024
- NCT06619340Sponsor investigatorPhase 4May 20, 2024
- NCT06619340OfficialPhase 4May 20, 2024
- NCT06619340Lead sponsorPhase 4May 20, 2024
- NCT05099276Lead sponsorPhase 4Nov 1, 2021
- NCT05099276Overall official - principal investigatorPhase 4Nov 1, 2021
- NCT05099276Reponsible party - principal investigatorPhase 4Nov 1, 2021
- NCT04575688Lead sponsorPhase 4Nov 30, 2020
Details
- Last known activity
- Nov 1, 2025